Market revenue in 2021 | USD 78.9 million |
Market revenue in 2030 | USD 569.8 million |
Growth rate | 24.6% (CAGR from 2021 to 2030) |
Largest segment | Oncology |
Fastest growing segment | CVD |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oncology, CVD, Neurological Diseases or conditions, Metabolic diseases, Infectious diseases |
Key market players worldwide | The Carlyle Group Inc, Mendel.ai, Median Technologies, SAI.TECH Global Corp, Alphabet Inc Class A, Exscientia PLC ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai-based clinical trials solution provider market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 23.19% in 2021. Horizon Databook has segmented the Germany ai-based clinical trials solution provider market based on oncology, cvd, neurological diseases or conditions, metabolic diseases, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
Germany has proven to be an attractive site for outsourcing clinical trials owing to availability of advanced medical expertise and easy access to patients. Low rate of saturation of competing trials and large population are promoting outsourcing.
This has increased development of technologically advanced solutions by local players, to increase adoption of such solutions for better clinical trial outsourcing and timely results with patient comfort. In addition, collaborations of large pharmaceutical companies as well as establishment of network in the country through resident companies are further anticipated to boost market growth.
It is a resident company of Johnson & Johnson Innovation. Thus, the penetration of technologically advanced solutions is expected to increase for better clinical trials. However, patient recruitment segment in Germany is still at an initial stage, as people are reluctant to participate in trials due to high sensitivity.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany ai-based clinical trials solution provider market, including forecasts for subscribers. This country databook contains high-level insights into Germany ai-based clinical trials solution provider market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account